Performance of Wheat for Air Revitalization and Food Production During the Lunar-Mars Life Support Test Project Phase III Test

1998 ◽  
Author(s):  
Daniel J. Barta ◽  
Keith Henderson
Keyword(s):  
Food Production ◽  
Life Support ◽  
Phase Iii ◽  
Test Project

The Lunar-Mars Life Support Test Project Phase III 90-day Test: The Crew Perspective

1998 ◽  
Author(s):  
J. F. Lewis ◽  
N. J. C. Packham ◽  
V. L Kloeris ◽  
L. N. Supra
Keyword(s):  
Life Support ◽  
Phase Iii ◽  
Test Project

Performance of the Physicochemical Air Revitalization System During the Lunar-Mars Life Support Test Project Phase III Test

1998 ◽  
Author(s):  
Sandra F. Brasseaux ◽  
John C. Graf ◽  
John F. Lewis ◽  
Karen E. Meyers ◽  
Melissa L. Rosenbaum ◽  
...  
Keyword(s):  
Life Support ◽  
Phase Iii ◽  
Test Project

Performance of the Water Recovery System During Phase II of the Lunar-Mars Life Support Test Project

1997 ◽  
Author(s):  
Charles Verostko ◽  
Karen Pickering ◽  
Fred Smith ◽  
Nigel Packham ◽  
John Lewis ◽  
...  
Keyword(s):  
Phase Ii ◽  
Life Support ◽  
Water Recovery ◽  
Recovery System ◽  
Test Project

scholarly journals Improving newborn heart rate assessment using a simple visual timer

2020 ◽  
Vol 4 (1) ◽  
pp. e000638
Author(s):  
Caroline Henry ◽  
David E Morris ◽  
Sophie Coleman ◽  
Andrea Pereira ◽  
Christian Tamakloe ◽  
...  
Keyword(s):  
Heart Rate ◽  
Phase I ◽  
Phase Ii ◽  
Life Support ◽  
Phase Iii ◽  
Developmental Approach ◽  
Three Phase ◽  
Assessment Time ◽  
Potential Benefits ◽  
Improved Accuracy

ObjectiveNewborn resuscitation relies on accurate heart rate (HR) assessment, which, during auscultation, is prone to error. We investigated if a 6 s visual timer (VT) could improve HR assessment accuracy during newborn simulation.DesignProspective observational study of newborn healthcare professionals.SettingThree-phase developmental approach: phase I: HR auscultation during newborn simulation using a standard clock timer (CT) or the VT; phase II: repeat phase I after using a bespoke training app (NeoRate); phase III: following the Newborn Life Support course, participants assessed random HRs using the CT or VT.Main outcome measuresHR accuracy (within ±10 beats/min, correct HR category, i.e. <60, 60–100 and >100 beats/min), assessment time and error-free rates were compared.ResultsOverall, 1974 HR assessments were performed with participants more accurate using the VT for ±10 beats/min (70% CT vs 86% VT, p<0.001) and correct HR category (78% CT vs 84% VT, p<0.01). The VT improved accuracy across all three phases. Additionally, following app training in phase II, the HR accuracy of both the CT and VT improved. The VT resulted in faster HR assessment times of 11 s (IQR 9–13) compared with the CT at 15 s (IQR 9–23, p<0.001). Error-free scenarios increased from 24% using the CT to 57% using the VT (p<0.001), with a shorter assessment time (CT 116 s (IQR 65–156) vs VT 53 s (IQR 50–64), p<0.001).ConclusionUsing a VT to assess simulated newborn HR combined with a training app significantly improves accuracy and reduces assessment time compared with standard methods. Evaluation in the clinical setting is required to determine potential benefits.

Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): Results of CapRI, a single-center, randomized phase III trial.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 2000-2000 ◽  
Author(s):  
Olivier Mir ◽  
Marie Ferrua ◽  
Aude Fourcade ◽  
Delphine Mathivon ◽  
Adeline Duflot-Boukobza ◽  
...  
Keyword(s):  
Anticancer Agents ◽  
Mobile Application ◽  
Life Support ◽  
Dose Intensity ◽  
Phase Iii ◽  
Cancer Center ◽  
Care Needs ◽  
Health Technologies ◽  
Grade 3

2000 Background: Various interventions aiming to improve a safe use of oral anti-cancer agents have previously been reported. These retrospective studies involved nurse-led follow-up and use of health technologies. However, the potential impact of these combined strategies is limited by a lack of rigorous methodology. Methods: We performed a randomized phase 3 trial comparing an intervention combining NNs and a mobile application vs. SOC in cancer pts treated with OAA (excluding hormonal therapy) in our tertiary cancer center. Pts initiating OAA (all types of cancer, PS < 3, life expectancy > 6 months), were randomized in a 1:1 basis. The intervention combined a nursing-led follow-up and a mobile application for patients. NNs provided regular phone follow-ups to manage symptoms and assess toxicities, adherence and supportive care needs. Pts had access to a mobile application to record tracking data, contact NNs via secure messaging or a dedicated phone line. The intervention lasted 6 months. The primary endpoint was the Relative Dose Intensity (RDI). Secondary endpoints included adherence, toxicity, response and survival, quality of life, pts experience (PACIC Score), end-of-life support, and economic estimation of the use of healthcare resources. Results: From October 2016 to May 2019, 609 pts (median age: 62 years, 20-92; PS2: 11.8%) were included. 39% were receiving oral chemotherapy, and 61% other OAA. The RDI was significantly higher in the CAPRI arm (93.4% ±0.26 vs. 89.4% ±0.19, p = 0.04). The CAPRI intervention also improved PACIC scores (mean: 2.94±0.83 vs. 2.67±0.89, p = 0.01), the number of unplanned hospitalizations (15.1% vs. 22.0%, p = 0.04), hospitalization duration (mean: 2.82±6.96 days vs. 4.44±9.60, p = 0.02), and treatment-related grade≥3 toxicities (27.6% vs. 36.9%, p = 0.02). Conclusions: Compared to SOC, the CAPRI intervention improved RDI, pts experience, hospitalizations and their duration, as well as the rate of treatment-related grade≥3 toxicities. This type of intervention should represent a new standard in pts receiving OAA. Clinical trial information: NCT02828462.

Sign in / Sign up

Export Citation Format

Share Document